| Bioactivity | Tranylcypromine (SKF 385) (GMP) is Tranylcypromine (HY-17447) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Tranylcypromine (SKF 385) is a potent monoamine oxidase (MAO) inhibitor[1][2]. |
| Invitro | Tranylcypromine (SKF 385) (GMP) 和 Laduviglusib (HY-10182) 联合使用可引起由 Oct4 和 Klf4 这两个因子转导的人原代角质形成细胞的重编程[2]。 |
| Name | Tranylcypromine (GMP) |
| CAS | 155-09-9 |
| Formula | C9H11N |
| Molar Mass | 133.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. TODA N, et al. The sympathomimetic effects of SKF-385 on blood pressure in dog. Jpn J Pharmacol. 1962;12:166-179. [2]. Wenlin Li, et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells. 2009 Dec;27(12):2992-3000. |
Tranylcypromine (GMP)
CAS: 155-09-9 F: C9H11N W: 133.19
Tranylcypromine (SKF 385) (GMP) isTranylcypromine (HY-17447) produced by using GMP guidelines. GMP small molecules work
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.